$BTCS
BTCS Inc. Stock $btcs

$btcs Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019301 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$561.2K	$385.8K	$311.5K
YoY Change	45.48%	23.84%	-44.67%
Cost Of Revenue	$168.8K	$95.01K	$82.01K
YoY Change	48.62%	15.85%	-40.51%
Gross Profit	$392.3K	$290.8K	$229.5K
YoY Change	44.17%	26.7%	-46.02%
Gross Profit Margin	69.91%	75.37%	73.67%
Selling, General & Admin	$567.4K	$545.2K	$616.1K
YoY Change	-8.52%	-11.5%	-70.88%
% of Gross Profit	144.63%	187.51%	268.45%
Research & Development	$163.8K	$146.5K	$201.6K
YoY Change	-9.47%	-27.32%	47.47%
% of Gross Profit	41.74%	50.4%	87.86%
Depreciation & Amortization	$1.490K	$1.495K	$1.153K
YoY Change	27.35%	29.66%	44.13%
% of Gross Profit	0.38%	0.51%	0.5%
Operating Expenses	$1.319M	$1.137M	$1.358M
YoY Change	-7.94%	-16.28%	-39.72%
Operating Profit	-$927.0K	-$846.1K	-$1.128M
YoY Change	-20.15%	-25.02%	-38.26%
Interest Expense	$287.3K	$10.69K	-$268.2K
YoY Change	-60.7%	-103.99%	-52.96%
% of Operating Profit
Other Income/Expense, Net	-$5.801M	$13.10M	-$285.0K
YoY Change	-4170.76%	-4697.43%	699.89%
Pretax Income	-$6.728M	$12.26M	-$1.413M
YoY Change	560.6%	-967.19%	-75.38%
Income Tax
% Of Pretax Income
Net Earnings	-$6.728M	$12.26M	-$1.413M
YoY Change	560.6%	-967.19%	-75.38%
Net Earnings / Revenue	-1198.85%	3177.15%	-453.72%
Basic Earnings Per Share	-$0.43	$0.78	-$0.10
Diluted Earnings Per Share	-$0.43	$0.63	-$0.10
COMMON SHARES
Basic Shares Outstanding	15.71M shares	15.69M shares	13.77M shares
Diluted Shares Outstanding	15.76M shares	19.41M shares	17.19M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$536.7K	$670.6K	$1.543M
YoY Change	-48.57%	-56.54%	-68.27%
Cash & Equivalents	$536.7K	$670.6K	$1.400M
Short-Term Investments			$100.0K
Other Short-Term Assets	$33.18M	$38.77M	$7.949M
YoY Change	296.81%	387.68%	14.92%
Inventory
Prepaid Expenses	$180.9K	$31.62K	$93.45K
Receivables
Other Receivables
Total Short-Term Assets	$33.72M	$39.44M	$9.492M
YoY Change	258.5%	315.47%	-19.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.500K	$8.995K	$9.999K
YoY Change	-15.1%	-10.04%	-13.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$100.0K	$100.0K
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$107.5K	$109.0K	$9.999K
YoY Change	1116.89%	990.06%	-99.89%
TOTAL ASSETS
Total Short-Term Assets	$33.72M	$39.44M	$9.492M
Total Long-Term Assets	$107.5K	$109.0K	$9.999K
Total Assets	$33.82M	$39.55M	$9.502M
YoY Change	259.3%	316.18%	-53.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$130.9K	$26.19K	$41.95K
YoY Change	-30.45%	-37.57%	-59.03%
Accrued Expenses	$639.3K	$32.61K	$45.38K
YoY Change	44.6%	-28.14%	1313.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$710.6K	$246.4K	$544.1K
YoY Change	-11.0%	-54.72%	-81.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$710.6K	$246.4K	$544.1K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$710.6K	$246.4K	$544.1K
YoY Change	-11.0%	-54.72%	-81.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.1M	-$126.4M	-$152.9M
YoY Change	-13.49%	-17.32%
Common Stock	$15.90K	$15.71K	$161.9M
YoY Change	-99.99%	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.11M	$39.30M	$8.958M
YoY Change
Total Liabilities & Shareholders Equity	$33.82M	$39.55M	$9.502M
YoY Change	259.3%	316.18%	-53.59%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$6.728M	$12.26M	-$1.413M
YoY Change	560.6%	-967.19%	-75.38%
Depreciation, Depletion And Amortization	$1.490K	$1.495K	$1.153K
YoY Change	27.35%	29.66%	44.13%
Cash From Operating Activities	-$924.1K	-$769.0K	-$1.126M
YoY Change	0.5%	-31.71%	6.71%
INVESTING ACTIVITIES
Capital Expenditures	$490.00	$18.72K
YoY Change	-99.97%
Acquisitions
YoY Change
Other Investing Activities	$550.4K	$0.00	$47.54K
YoY Change	-67.09%	-100.0%	-84.67%
Cash From Investing Activities	$549.9K	-$18.72K	-$86.48K
YoY Change	25594.86%	-78.35%	-98.95%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	240.3K		$508.8K
YoY Change	-42.47%		-94.97%
NET CHANGE
Cash From Operating Activities	-924.1K	-$769.0K	-$1.126M
Cash From Investing Activities	549.9K	-$18.72K	-$86.48K
Cash From Financing Activities	240.3K		$508.8K
Net Change In Cash	-133.9K	-$787.7K	-$703.7K
YoY Change	-73.2%	11.94%	-183.36%
FREE CASH FLOW
Cash From Operating Activities	-$924.1K	-$769.0K	-$1.126M
Capital Expenditures	$490.00	$18.72K
Free Cash Flow	-$924.6K	-$787.7K	-$1.126M
YoY Change	-64.3%	-30.04%	-115.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	BTCS	Receivable For Capital Shares Sold ReceivableForCapitalSharesSold		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins		usd
CY2023Q1	BTCS	Increase Decrease In Receivable For Capital Shares Sold IncreaseDecreaseInReceivableForCapitalSharesSold		usd
CY2024Q1	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	BTCS	Cost Of Builder Revenues CostOfBuilderRevenues		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
CY2024Q1	BTCS	Warrant Liabilities Classification WarrantLiabilitiesClassification		usd
CY2023Q1	BTCS	Warrant Liabilities Classification WarrantLiabilitiesClassification		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40792
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	BTCS Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1096644
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	9466 Georgia Avenue #124
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
CY2024Q1	dei	City Area Code CityAreaCode	(202)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	430-6576
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2024Q1	dei	Trading Symbol TradingSymbol	BTCS
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15705415	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1458327	usd
CY2023Q4	BTCS	Stable Coins StableCoins	21044	usd
CY2023Q4	BTCS	Crypto Assets Currencies CryptoAssetsCurrencies	302783	usd
CY2023Q4	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	24900146	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	31620	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62461	usd
CY2023Q4	BTCS	Receivable For Capital Shares Sold ReceivableForCapitalSharesSold	291440	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	39437786	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	27036201	usd
CY2024Q1	us-gaap	Investments Investments	100000	usd
CY2023Q4	us-gaap	Investments Investments	100000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15705415	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15705415	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	15707	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15322	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	163141291	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162263634	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126420517	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138677103	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	39300419	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26165791	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39546781	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27146691	usd
CY2024Q1	us-gaap	Revenues Revenues	385773	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	95012	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	82014	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	290761	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	229494	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	487599	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	609829	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	146549	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201625	usd
CY2024Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	455779	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	462090	usd
CY2024Q1	us-gaap	Marketing Expense MarketingExpense	57602	usd
CY2023Q1	us-gaap	Marketing Expense MarketingExpense	6243	usd
CY2024Q1	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	10687	usd
CY2023Q1	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	7554	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1136842	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1272233	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	13102667	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6293207	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	285000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13102667	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6008207	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	12256586	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4965468	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15691677	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13673126	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19410550	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17187025	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26165791	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	878042	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	12256586	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	39300419	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14317540	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14317540	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	531617	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4965468	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	20323408	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4986377	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	12256586	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4965468	usd
CY2024Q1	us-gaap	Depreciation Depreciation	1495	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1153	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	878042	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	531617	usd
CY2024Q1	BTCS	Blockchain Infrastructure Revenue BlockchainInfrastructureRevenue	385773	usd
CY2023Q1	BTCS	Blockchain Infrastructure Revenue BlockchainInfrastructureRevenue	311508	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	285000	usd
CY2024Q1	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	10687	usd
CY2023Q1	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	7554	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	13102667	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	6293207	usd
CY2024Q1	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins	6247	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-30841	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-30278	usd
CY2024Q1	BTCS	Increase Decrease In Receivable For Capital Shares Sold IncreaseDecreaseInReceivableForCapitalSharesSold	291440	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-28865	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-34773	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-705673	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-292506	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-769014	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1126032	usd
CY2024Q1	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	18719	usd
CY2023Q1	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	134019	usd
CY2023Q1	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	47543	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18719	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-86476	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	508783	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	508783	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-787733	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-703725	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1458327	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2146783	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	670594	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1443058	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs1DY6DnKCCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zNw1IpmfTP9g">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation in the unaudited condensed financial statements and accompanying notes. The reclassifications did not have a material impact on the Company’s unaudited condensed financial statements and related disclosures. The impact on any prior period disclosures was immaterial.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Cash	670000	usd
CY2023Q4	us-gaap	Cash Cash	1458000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	144000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	933000	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	11000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	8000	usd
CY2024Q1	us-gaap	Revenues Revenues	385773	usd
CY2023Q1	us-gaap	Revenues Revenues	311508	usd
CY2024Q1	us-gaap	Revenues Revenues	385773	usd
CY2023Q1	us-gaap	Revenues Revenues	311508	usd
CY2024Q1	BTCS	Cost Of Staking Revenues CostOfStakingRevenues	51953	usd
CY2023Q1	BTCS	Cost Of Staking Revenues CostOfStakingRevenues	82014	usd
CY2024Q1	BTCS	Cost Of Builder Revenues CostOfBuilderRevenues	43059	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	95012	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	82014	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zbk5p425Mg91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_z2TpebpgepR5">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.
CY2024Q1	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	58000	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6000	usd
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	4986000	usd
CY2024Q1	BTCS	Cost Of Platform Operator Crypto Asset Held For User CostOfPlatformOperatorCryptoAssetHeldForUser	22187698	usd
CY2024Q1	srt	Platform Operator Crypto Asset Held For User PlatformOperatorCryptoAssetHeldForUser	38720775	usd
CY2024Q1	BTCS	Crypto Assets CryptoAssets	38720775	usd
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	38820775	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q4	BTCS	Crypto Assets CryptoAssets	25202929	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	25302929	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	100000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	285000	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	498750	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1200000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8700	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1200000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.12
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17150	usd
CY2024Q1	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1145000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.15
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1300	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1606373	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.25
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	300000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.71
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	100000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.63
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1806373	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.09
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	248426	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	286553	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	6419	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	712092	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	26193	usd
CY2023Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	55058	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32612	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	767150	usd
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	0	usd
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	710000	usd
CY2024Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2024Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	109000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	95000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126421000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-769000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-019301-index-headers.html	Edgar Link	pending
0001493152-24-019301-index.html	Edgar Link	pending
0001493152-24-019301.txt	Edgar Link	pending
0001493152-24-019301-xbrl.zip	Edgar Link	pending
btcs-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
btcs-20240331_def.xml	Edgar Link	unprocessable
btcs-20240331_lab.xml	Edgar Link	unprocessable
btcs-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
btcs-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BTCS
BTCS Inc. Stock $btcs

2024 Q2 Form 10-Q Financial Statement

#000149315224019301 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS BTCS Inc. Stock $btcs

2024 Q2 Form 10-Q Financial Statement

#000149315224019301 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS
BTCS Inc. Stock $btcs